Isn't EPY a fintech company and we all know what happened to the BNPL sector. RAP will need to continue their uptrend of revenue for ResAppDx and then they need to do a CR at 12c immediately after the NO vote with other big Insto investments after the publicity of the Pfizer but I suspect Pfizer will up their bid to the recommended price (what is $50M AUD to them anyway).